Contact
Please use this form to send email to PR contact of this press release:
Neos Therapeutics Completes Resubmission of NDA for Cotempla XR-ODT for the Treatment of ADHD
TO:
Please use this form to send email to PR contact of this press release:
Neos Therapeutics Completes Resubmission of NDA for Cotempla XR-ODT for the Treatment of ADHD
TO: